Скачать или смотреть Pharma Executives Are Doing Equity Comp Wrong—Here's Why

If you’re a pharma executive, you’ve likely worked incredibly hard to reach a level where your compensation includes Restricted Stock Units (RSUs) or company equity. But are you actually making the most of it?

Many high-achieving women in pharma unintentionally leave money on the table by trying to time the market, holding too much company stock, or underestimating their tax liability.

I’m Hazel Secco, CFP®, CDFA®, and I help women in life sciences and biotech take control of their wealth—so they can create a life with more freedom, fulfillment, and confidence.

In this video, I’ll share:
✅ The #1 mistake executives make with their RSUs
✅ What smart diversification really looks like
✅ How to avoid surprise tax bills
✅ And what to do instead of waiting for the “perfect” time to sell
💡 Your equity compensation is a powerful wealth-building tool—but only when used with intention.

📌 Ready to feel confident in your financial strategy? Book a quick call to learn more: https://oncehub.com/book-an-intro-call

Hazel Secco, CFP® | Helping women in pharma build wealth with purpose

Disclosure: Content in this material is for general information only and not intended to provide specific advice or recommendations for any individual.
There is no guarantee that a diversified portfolio will enhance overall returns or outperform a non-diversified portfolio. Diversification does not protect against market risk. No investment strategy assures a profit or protects against loss.
This information is not intended to be a substitute for specific individualized tax advice. Please consult a qualified tax advisor regarding your personal tax situation.
Securities and advisory services offered through LPL Financial, a Registered Investment Advisor. Member FINRA/SIPC.